How Can Life Sciences Leaders Maximize Inward Investment?

RTP, NC, October 20, 2022 — GeneCoda® announced today the release of  “How Can Life Sciences Leaders Maximize Inward Investment?” which is a publication pertains to attracting and using investor proceeds generally found in Seed to Series A / B funded companies.

While companies in this universe are already incorporated, have a business plan and an investor slide deck, this guide can serve as a blueprint for operating executives that may have less familiarity with efficient methods of growing companies..

What Capital Efficiency Really Means…

✔ Should you “rent or buy” Talent and Facilities and when should this change?

✔ IP, Supply Chain, Product Development & Milestone planning are critical to success but what are company’s getting wrong?

✔ How the commercialization of disruptive technologies differ from proven technologies? Failure here isn’t an option.

To get your complimentary copy complete the following form and you will receive an email with the publication!